Triptorelin embonate Prescribing at THE RED HOUSE GROUP
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
50
Total Quantity
50
NHS Cost
£20.7K
vs National Avg
+402.3%
THE RED HOUSE GROUP prescribed 50 items of Triptorelin embonate over the last 12 months at a cost of £20,701 to the NHS. This is 402.3% above the national average prescribing rate. Triptorelin embonate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jun 2026
4
Jun 2026
2
Jun 2026
5
Jun 2026
7
Jun 2026
2
Jun 2026
4
Jun 2026
1
Jun 2026
2
Jun 2026
6
Jun 2026
4
Jun 2026
6
Jun 2026
7
Prescribing Details
| Total Items | 50 |
|---|---|
| Total Quantity | 50 |
| Total NHS Cost | £20,701 |
| Presentations | 2 different forms |
| vs National Average | +402.3% |
Triptorelin embonate Prescribing Comparison
| This practice | 50 items |
|---|---|
| National average per practice | 10 items |
| Difference | +402.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.